Short-term cardiovascular complications of multi-system inflammatory syndrome in children (MIS-C) in adolescents and children
OI Hejazi, YH Loke, AS Harahsheh - Current Pediatrics Reports, 2021 - Springer
Abstract Purpose of Review We provide the readers with a review of cardiac complications
in children with multi-system inflammatory syndrome in children (MIS-C) and its short-term …
in children with multi-system inflammatory syndrome in children (MIS-C) and its short-term …
Systematic review and meta‐analysis on the serological, immunological, and cardiac parameters of the multisystem inflammatory syndrome (MIS‐C) associated with …
G Ghazizadeh Esslami, S Mamishi… - Journal of Medical …, 2023 - Wiley Online Library
Diverse clinical and laboratory features of multisystem inflammatory syndrome (MIS‐C) have
been reported in the literature. Despite the worldwide distribution, systemic studies …
been reported in the literature. Despite the worldwide distribution, systemic studies …
COVID-19–related multisystem inflammatory syndrome in children presenting with new-onset type 1 diabetes in severe ketoacidosis: a case series
HH Aly, EM Fouda, AA Kotby, SM Magdy… - Diabetes …, 2022 - Am Diabetes Assoc
OBJECTIVE To report and describe cases of children presenting with coronavirus disease
2019 (COVID-19)-related multisystem inflammatory syndrome in children (MIS-C) with new …
2019 (COVID-19)-related multisystem inflammatory syndrome in children (MIS-C) with new …
A retrospective comparative analysis of factors affecting the decision and outcome of initial intravenous immunoglobulin alone or intravenous immunoglobulin plus …
İ Devrim, E Böncüoğlu, E Kıymet, Ş Şahinkaya… - Pediatric …, 2022 - Springer
Background For children with the multisystem inflammatory syndrome (MIS-C), intravenous
immunoglobulins (IVIG) with or without methylprednisolone are the most effective treatment …
immunoglobulins (IVIG) with or without methylprednisolone are the most effective treatment …
Ten-month follow-up of patients with covid-19 temporally related multi-system inflammatory syndrome in children: the experience of the children hospital of Palermo
MC Maggio, S Giordano, MC Failla… - Italian Journal of …, 2023 - Springer
Abstract Background In Sicily, the first wave of COVID-19 showed a low epidemic impact in
paediatric population, while the second and the third waves had a higher impact on clinical …
paediatric population, while the second and the third waves had a higher impact on clinical …
Early is superior to late plasma exchange for severe multisystem inflammatory syndrome in children
B Katlan, S Kesici, D Karacanoğlu… - Journal of clinical …, 2022 - Wiley Online Library
Background Multisystem inflammatory syndrome in children (MIS‐C) can be life threatening
in severe cases because of uncontrolled inflammation and multi‐organ failure. In this study …
in severe cases because of uncontrolled inflammation and multi‐organ failure. In this study …
Cardiovascular outcomes in children with multisystem inflammatory syndrome treated with therapeutic plasma exchange
T Tunçer, F Varol - Children, 2022 - mdpi.com
Background: Multisystem inflammatory syndrome in children is a new, rare, post-infectious
complication of SARS-CoV-2 infection in children. The aim of this study was to display the …
complication of SARS-CoV-2 infection in children. The aim of this study was to display the …
In-hospital unfavorable outcomes of MIS-C during 2020–2022: a systematic review
G Alvarado-Gamarra, K Alcalá-Marcos… - European Journal of …, 2024 - Springer
Studies on the severity in multisystem inflammatory syndrome in children (MIS-C) show
heterogeneous results and may not reflect a global perspective. This systematic review aims …
heterogeneous results and may not reflect a global perspective. This systematic review aims …
Clinical and laboratory characteristics of multisystem inflammatory syndrome in children associated with COVID‐19 in Egypt: a tertiary care hospital experience
TA Abdelaziz, DA Abdulrahman, EG Baz… - … of Paediatrics and …, 2023 - Wiley Online Library
Aim We aimed to evaluate MIS‐C patients' clinical manifestations, laboratory test results and
mortality outcomes in an Egyptian tertiary care university hospital. Methods We conducted a …
mortality outcomes in an Egyptian tertiary care university hospital. Methods We conducted a …
Development of a biomarker signature using grating-coupled fluorescence plasmonic microarray for diagnosis of MIS-C
M Maltz-Matyschsyk, CK Melchiorre… - … in Bioengineering and …, 2023 - frontiersin.org
Multisystem inflammatory syndrome in children (MIS-C) is a rare but serious condition that
can develop 4–6 weeks after a school age child becomes infected by SARS-CoV-2. To date …
can develop 4–6 weeks after a school age child becomes infected by SARS-CoV-2. To date …